Translating Trips to Trials: Current Challenges in Psychedelics' Clinical Development (p.34-37) Adrienne Rivlin Jess Sharpe Read more
Article Life Sciences & Pharma Advancement in Antimicrobial Resistance Management in Asia Pacific July 12, 2022
Published Articles Mental and Behavioral Health Trip or No Trip? The Diverging Development of Psychedelic Drugs for Mental Health … December 15, 2022
Executive Insights Sustainability From Commitment to Reality: Overcoming the Corporate Sustainability Struggle October 4, 2022
Article Mental and Behavioral Health A Test of Resilience: Looking Forward to Psychedelics Funding in 2023 March 7, 2023
Executive Insights Biotech and Pharmaceuticals Shareholder Value Creation for First-Time Launchers: Two Decades of Learnings December 30, 2022
Executive Insights Organization & Performance Getting Post-Merger Integration Right: What Are the Keys to Success? March 31, 2022
